Rachel E. Sherman's most recent trade in GeneDx Holdings Corp - Ordinary Shares - Class A was a trade of 45,454 Restricted Stock Unit done . Disclosure was reported to the exchange on May 2, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
GeneDx Holdings Corp - Ord...
|
Rachel E. Sherman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 0 | - | - | Restricted Stock Unit | |
GeneDx Holdings Corp - Ord...
|
Rachel E. Sherman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 58,290 | - | 0 | Class A Common Stock | |
GeneDx Holdings Corp - Ord...
|
Rachel E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 78,914 | 78,914 | - | - | Stock Option | |
GeneDx Holdings Corp - Ord...
|
Rachel E. Sherman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 0 | - | - | Restricted Stock Unit | |
GeneDx Holdings Corp - Ord...
|
Rachel E. Sherman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 12,836 | - | - | Class A Common Stock | |
GeneDx Holdings Corp - Ord...
|
Rachel E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 31,659 | 31,659 | - | - | Restricted Stock Unit | |
GeneDx Holdings Corp - Ord...
|
Rachel E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
GeneDx Holdings Corp - Ord...
|
Rachel E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit | |
GeneDx Holdings Corp - Ord...
|
Rachel E. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 363,223 | 363,223 | - | - | Stock Option (Right to Buy) |